Jun‐Yan Liu
Impact in
- Biochemistry top 0.1%
- Eicosanoids and Hypertension Pharmacology
- Pharmacology top 0.5%
- Microbial Natural Products and Biosynthesis
- Pharmacogenetics and Drug Metabolism
- Inflammatory mediators and NSAID effects
- Fungal Biology and Applications
Papers in
- Biochemistry 42
- Eicosanoids and Hypertension Pharmacology 41
- Pharmacology 30
- Inflammatory mediators and NSAID effects 14
- Microbial Natural Products and Biosynthesis 12
- Pharmacogenetics and Drug Metabolism 8
- Co-authors
- Bruce D. HammockSung Hee HwangChristophe MorisseauRen Xiang TanNipavan ChiamvimonvatJun YangChen XuArzu Ulu
- Journals
- Proceedings of the National Academy of Sciences (9 papers)Journal of Medicinal Chemistry (5 papers)Frontiers in Pharmacology (4 papers)Biochemical Pharmacology (3 papers)Helvetica Chimica Acta (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Jun‐Yan Liu
118 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 142
- Biochemistry 1.7k
- Pharmacology 475
- Pharmacology 857
- Endocrinology, Diabetes and Metabolism 733
- Pathology and Forensic Medicine 587
Countries citing papers authored by Jun‐Yan Liu
This map shows the geographic impact of Jun‐Yan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun‐Yan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun‐Yan Liu more than expected).
Fields of papers citing papers by Jun‐Yan Liu
This network shows the impact of papers produced by Jun‐Yan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun‐Yan Liu. The network helps show where Jun‐Yan Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun‐Yan Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 3 | |
| 6 | 2022 | 0 | |
| 7 | 2021 | 133 | |
| 8 | 2021 | 19 | |
| 9 | 2020 | 6 | |
| 10 | 2019 | 40 | |
| 11 | 2018 | 4 | |
| 12 | 2014 | 47 | |
| 13 | 2013 | 34 | |
| 14 | 2011 | 20 | |
| 15 | 2009 | 68 | |
| 16 | 2009 | 84 | |
| 17 | 2009 | 113 | |
| 18 | 2004 | 128 | |
| 19 | A New Antimicrobial Flavonol Glycoside from Alchornea Davidii | 2003 | 3 |
| 20 | 2003 | 61 |
About Jun‐Yan Liu
Jun‐Yan Liu is a scholar working on Biochemistry, Pharmacology, Nephrology, Endocrinology, Diabetes and Metabolism and Pharmacology, having authored 127 papers that have together received 4.1k indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (41 papers), Hormonal Regulation and Hypertension (18 papers), Inflammatory mediators and NSAID effects (14 papers), Alcohol Consumption and Health Effects (14 papers), Microbial Natural Products and Biosynthesis (12 papers), Metabolomics and Mass Spectrometry Studies (8 papers), Pharmacogenetics and Drug Metabolism (8 papers) and Cancer, Hypoxia, and Metabolism (7 papers). The work is most often cited by research in Biochemistry (1.7k citations), Pharmacology (475 citations), Pharmacology (857 citations), Endocrinology, Diabetes and Metabolism (733 citations) and Pathology and Forensic Medicine (587 citations). Jun‐Yan Liu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Bruce D. Hammock, Sung Hee Hwang, Christophe Morisseau, Ren Xiang Tan, Nipavan Chiamvimonvat, Jun Yang, Chen Xu, Ren Xiang Tan, Arzu Ulu and Ning Li. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry, Frontiers in Pharmacology, Biochemical Pharmacology and Helvetica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.